✓ Last verified: February 15, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Greenbrook TMS is a national network of mental wellness centers specializing in FDA-cleared treatments for depression. The Fairfield location offers Spravato® (esketamine) nasal spray alongside NeuroStar® TMS therapy, providing two of the most clinically validated non-traditional depression treatments under one roof. Greenbrook is known for strong insurance acceptance and a structured, research-backed approach to treatment-resistant depression.
| Google Reviews | ⭐ National chain – Positive patient feedback |
| Location | Fairfield, Connecticut |
| Address | 140 Sherman Street, 5th Floor, Fairfield, CT 06824 |
| Phone | (855) 940-4867 |
| Website | greenbrooktms.com |
| Treatments | Spravato® (Esketamine) Nasal Spray, NeuroStar® TMS Therapy |
| Conditions Treated | Treatment-Resistant Depression, Major Depressive Disorder |
| Cost | Covered by most insurance plans |
| Insurance | Most major insurance accepted for both TMS and Spravato® |
| KAP Available | Spravato® (esketamine) only – No IV ketamine or KAP |
| Clinical Lead | Greenbrook medical team with board-certified psychiatrists |
HealingMaps Take: Greenbrook TMS Fairfield is best suited for patients specifically seeking Spravato® (esketamine) or TMS therapy with strong insurance coverage. As a large national network, Greenbrook brings standardized protocols and broad insurance acceptance — a significant advantage for patients who need their treatment covered. However, they do not offer IV ketamine infusions or ketamine-assisted psychotherapy, so patients looking for those modalities will need to look elsewhere. The Fairfield location offers a convenient option for Fairfield County residents seeking FDA-approved depression treatments in a professional clinical setting.
Market Position: Greenbrook TMS Fairfield is a Spravato-certified clinic in the Fairfield metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
⚠ FDA-cleared indications for TMS therapy: treatment-resistant major depressive disorder (MDD), obsessive-compulsive disorder (OCD, Deep TMS only), anxious depression, short-term smoking cessation, and adolescent MDD (ages 15–21). Use of TMS for other conditions including PTSD, bipolar depression, fibromyalgia, and other indications is off-label — not currently FDA-cleared for those specific indications. Discuss your condition with the clinic to understand insurance coverage and clinical evidence.
Industry pricing reference. Greenbrook TMS Fairfield’s posted price: Covered by most insurance plans. Contact the clinic for any package or sliding-scale options. The calculator above shows metro-level cost estimates across protocols.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Connecticut, state-level prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
11.4% of ketamine inquiries cite anxiety as the primary condition — the third-most-common driver of demand after depression and PTSD. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 2-question summary is matched to the protocols and conditions Greenbrook TMS Fairfield treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — Greenbrook TMS Fairfield offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
Greenbrook TMS Fairfield treats depression via Spravato (FDA-cleared for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
This clinic provides three FDA-cleared interventional psychiatry options: ketamine therapy, Spravato (esketamine), and TMS therapy. TMS sessions take 19 to 37 minutes (or 3 minutes for the iTBS protocol), with no anesthesia, sedation, or controlled-substance handling. This clinic uses BrainsWay Deep TMS, the only TMS device with standalone FDA clearance for OCD via the H7 coil. Read our complete guide to TMS therapy for FDA-cleared conditions, device differences, insurance coverage by carrier, and what to expect at your first appointment. Browse verified TMS clinics in our directory.
View all REMS-certified Spravato clinics in Connecticut and across the United States.
Leave a Reply